The report "Membrane Chromatography Market by Product (Cartridges, Capsules, Cassettes, Syringe Filters, Spin Column), Technique (Ion Exchange, Affinity), Operation Mode (Flow Through, Bind Elute), Material (PES, Cellulose, Hydrogel) - Global Forecast to 2029", is projected to reach USD 637 million by 2029 from an estimated USD 321 million in 2024, at a CAGR of 14.7% from 2024 to 2029.
Download PDF Brochure:
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=151487196
Browse
- 416
Market Data Tables
- 52
Figures
- 348
Pages and in-depth TOC on " Membrane
Chromatography Market - Global Forecast to 2028”
Some of the prominent key players are:
- Danaher
Corporation (US),
- Sartorius AG
(Germany),
- Merck KGaA
(Germany),
- Thermo Fisher
Scientific Inc. (US),
- 3M (US),
- Donaldson
Company, Inc. (US), and many more......
Mergers &
acquisitions, investments & expansions, partnerships & collaborations,
and new product developments are some of the major strategies adopted by these
key players to enhance their positions in the Membrane Chromatography Market.
DRIVER: Increasing biopharmaceutical R&D
In recent
years, companies are significantly investing in biopharmaceutical research
& development (R&D) in order to cater to the increasing demand for
biopharmaceuticals. Globally, the demand for biopharmaceuticals is increasing
due to a significant rise in the number of chronic illnesses, such as cancer,
diabetes, and neurological and cardiovascular conditions, worldwide. The
growing R&D expenditure by biopharmaceutical companies is accelerating the
growth of the market. For instance, according to AseBio, in 2022, R&D
investments by biotech companies in Spain increased by 16% to reach USD 1,093.8
million (EUR 1,038 million).
OPPORTUNITY: Shift towards single-use technologies
Single-use
membrane chromatography systems offer several advantages, including
reduced risk of cross-contamination, faster turnaround times, and lower capital
investment. The adoption of single-use technologies in bioprocessing is
expected to grow, driven by the demand for cost-effective and flexible
solutions. Companies are focusing on the adoption of single-use technologies
through collaborations or partnerships for effective downstream purification
processes. For instance, in December 2022, W. L. Gore & Associates, Inc.
collaborated with AGC Biologics to improve downstream purification processes
through increased productivity of the Protein A step, enabling a full
single-use downstream process. The collaboration includes the family of GORE
Protein Capture Devices with Protein A, which improves productivity in Protein
A affinity purification and provides high binding capacity.
Market Segmentation:
- Based on product,
the membrane chromatography market is segmented into capsules, cassettes
and cartridges, syringe filters, filter plates, spin columns, membrane
discs and sheets, and other consumables & accessories. The capsules,
cassettes, and cartridges segment dominated the market in 2023 and is
expected to dominate the market in the forecast period.
- Based on
technique, the membrane chromatography market is segmented into
flow-through membrane chromatography and bind-elute membrane
chromatography. In 2023, the flow-through membrane chromatography segment
dominated the market owing to the focus on the development of biologics
such as monoclonal antibodies.
- Based on end
user, the membrane chromatography market is segmented into pharmaceutical
& biopharmaceutical companies, CROs and CDMOs, and academic and
research institutes. The pharmaceutical & biopharmaceutical companies
segment is estimated to register the highest growth rate during the
forecast period.
- Based on the
region, the membrane chromatography market is segmented into six major
regions: North America, Europe, Asia Pacific, Latin America, Middle East,
and Africa. The Asia Pacific is anticipated to register the fastest growth
in the membrane chromatography market owing to the increasing focus on the
development of novel biopharmaceuticals, high government investments &
funding for R&D, and the booming healthcare sector.
Recent Developments of The Membrane Chromatography Industry:
- In February 2024,
Thermo Fisher Scientific Inc. opened a new sterile drug facility in
Singapore to deliver new medicines and vaccines in the Asia Pacific
market. The strategic investment complements new research capabilities at
Thermo Fisher Scientific’s Customer Experience Center and Bioprocess
Design Center. The Customer Experience Center includes 250 products across
diverse fields, including molecular biology, genetic analysis sequencing,
chromatography mass spectrometry, and cell therapy.
- In January 2023,
Agilent Technologies expanded its state-of-the-art manufacturing capacity
of nucleic acid-based therapeutics. The company invested USD 725 million
for this expansion.
- In February 2022,
Sartorius AG acquired Novasep’s chromatography division. The portfolio
acquired comprises chromatography systems primarily suited for smaller
biomolecules, such as oligonucleotides, peptides, and insulin, as well as
innovative systems for continuous manufacturing of biologics. The
acquisition aims to generate additional non-organic sales revenue for
Sartorius AG.
Request for Sample Pages: - https://www.marketsandmarkets.com/requestsampleNew.asp?id=151487196
The new research
study consists of an industry trend analysis of the market. The new research
study consists of industry trends, pricing analysis, patent analysis,
conference and webinar materials, key stakeholders, and buying behaviour in the
market. Growth of the can be attributed to factors such as the
rising demand for biopahramceuticals and increasing focus on advancement of
biotechnology sector. However, restrictions on use of fluorinated substances
and limited usage of membrane chromatography in large scale manufacturing may
hamper the growth of the market.
Related News:
-
No comments:
Post a Comment